SecSonar.com

BioCardia, Inc. (BCDA)

BioCardia, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

BioCardia, Inc. (BCDA) is a Biotechnology company based in US with a market capitalization of $5.5M. Free cash flow was negative at -$7.4M. This page tracks BCDA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 17 employees · IPO Nov 13, 1996

Valuation

Valuation & price

$1.01 · as of May 17, 2026 · -58.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

6.16

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.40$1.60$0.80Jul 25Dec 25Jul 26Jul 7, 25$2.10Jul 9, 25$2.36Jul 11, 25$2.39Jul 15, 25$2.28Jul 17, 25$2.28Jul 21, 25$2.34Jul 23, 25$2.40Jul 25, 25$2.35Jul 29, 25$2.22Jul 31, 25$2.14Aug 4, 25$1.96Aug 6, 25$1.71Aug 11, 25$1.68Aug 13, 25$1.86Aug 15, 25$1.92Aug 19, 25$1.87Aug 21, 25$1.81Aug 25, 25$1.95Aug 27, 25$1.94Aug 29, 25$1.98Sep 3, 25$2.04Sep 5, 25$2.06Sep 9, 25$2.11Sep 11, 25$2.27Sep 16, 25$1.70Sep 18, 25$1.17Sep 22, 25$1.11Sep 24, 25$1.48Sep 26, 25$1.42Sep 30, 25$1.29Oct 2, 25$1.35Oct 6, 25$1.40Oct 8, 25$1.42Oct 10, 25$1.34Oct 14, 25$1.55Oct 16, 25$1.45Oct 21, 25$1.49Oct 23, 25$1.40Oct 27, 25$1.31Oct 29, 25$1.31Oct 31, 25$1.40Nov 4, 25$1.33Nov 6, 25$1.28Nov 10, 25$1.29Nov 12, 25$1.30Nov 14, 25$1.23Nov 18, 25$1.29Nov 20, 25$1.28Nov 25, 25$1.43Nov 28, 25$1.45Dec 2, 25$1.37Dec 4, 25$1.47Dec 8, 25$1.43Dec 10, 25$1.47Dec 12, 25$1.45Dec 16, 25$1.28Dec 18, 25$1.28Dec 22, 25$1.29Dec 24, 25$1.27Dec 29, 25$1.23Jan 2, 26$1.27Jan 6, 26$1.27Jan 8, 26$1.32Jan 12, 26$1.42Jan 14, 26$1.42Jan 16, 26$1.40Jan 21, 26$1.28Jan 23, 26$1.34Jan 27, 26$1.32Jan 29, 26$1.26Feb 2, 26$1.21Feb 4, 26$1.09Feb 9, 26$1.26Feb 11, 26$1.18Feb 13, 26$1.14Feb 18, 26$1.16Feb 20, 26$1.13Feb 24, 26$1.17Feb 26, 26$1.24Mar 2, 26$1.35Mar 4, 26$1.19Mar 6, 26$1.18Mar 10, 26$1.27Mar 12, 26$1.27Mar 17, 26$1.28Mar 19, 26$1.20Mar 23, 26$1.20Mar 25, 26$1.20Mar 27, 26$1.16Mar 31, 26$1.21Apr 2, 26$1.20Apr 7, 26$1.19Apr 9, 26$1.17Apr 13, 26$1.19Apr 15, 26$1.19Apr 17, 26$1.18Apr 22, 26$1.20Apr 24, 26$1.16Apr 28, 26$1.14Apr 30, 26$1.14May 4, 26$1.13May 6, 26$1.11May 8, 26$1.11May 12, 26$1.12May 14, 26$1.09May 18, 26$0.90May 20, 26$0.92May 22, 26$0.95May 28, 26$0.92Jun 1, 26$0.92Jun 3, 26$0.87Jun 5, 26$1.03Jun 9, 26$0.86Jun 11, 26$0.80Jun 15, 26$0.83Jun 17, 26$0.95Jun 22, 26$0.97Jun 24, 26$1.06Jun 26, 26$1.20Jul 2, 26$1.20
$0.8052-week range$2.42
Loading valuation history…

Fundamentals

Key fundamentals

$5.5M

Market cap

—

Revenue growth (YoY)

-7463.8%

Gross margin

-$7.4M

Free cash flow (USD)

-$2M

Net debt

Net cash position

143.0%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$576.0KFY 2017$479.0KFY 2018$625.0KFY 2019$710.0KFY 2020$145.0KFY 2021$1.0MFY 2022$1.4MFY 2023$477.0KFY 2024$58.0KFY 2025$0.00
$576K$0

Free cash flow by year

2016 → 2025

FY 2016$-5.5MFY 2017$-8.8MFY 2018$-11.1MFY 2019$-9.6MFY 2020$-12.4MFY 2021$-10.5MFY 2022$-10.6MFY 2023$-10.0MFY 2024$-8.0MFY 2025$-7.4M
-$5.5M-$7.4M

Gross margin by year

2021 → 2024

FY 202137.0%FY 2022-553.4%FY 2023-1519.7%FY 2024-7463.8%
37.0%-7463.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.21)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventShareholder UpdateJun 18, 2026Filing
  • 8-K eventCompliance UpdateJun 12, 2026Filing
  • 8-K eventShare Sale AnnouncementJun 8, 2026Filing
  • 8-K eventFDA Meeting Minutes ReceivedJun 5, 2026Filing
  • 8-K eventRegulatory Submission SupportMay 28, 2026Filing
  • 8-K eventClinical Trial ResultsMay 21, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 15, 2026Filing
  • 8-K eventFDA Meeting OutcomeMay 8, 2026Filing
  • 8-K eventPatent AllowanceApr 28, 2026Filing

Questions

Frequently asked questions

What is BioCardia, Inc.'s market cap?

BioCardia, Inc. (BCDA) has a market capitalization of $5.5M.

What is BCDA's P/E ratio?

A meaningful P/E ratio is not available for BCDA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is BCDA's price-to-book (P/B) ratio?

BCDA trades at 6.16 times book value per share.

When did BioCardia, Inc. last report earnings?

BCDA last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying BCDA stock?

SEC Form 4 filings show no open-market insider buys at BioCardia, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

MLEC

Moolec Science S.A.

$5.5M

NITO

N2OFF, Inc.

$5.5M

XTLB

XTL Biopharmaceuticals Ltd.

$5.7M

APM

Aptorum Group Limited

$5.3M

RADX

Radiopharm Theranostics Limited

$5.8M

CELZ

Creative Medical Technology Holdings, Inc.

$5.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.